The enzyme O-GlcNAc transferase harbours a new type of lipid binding site; overexpression of the enzyme in the liver of mice causes insulin resistance and dyslipidaemia, underscoring the pivotal contribution of sugar modifications to insulin resistance and type 2 diabetes.
- Xiaoyong Yang
- Pat P. Ongusaha
- Ronald M. Evans